SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE)

CUSIP: 83587F202

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COMMON STOCK
Total 13F shares
3,404,417
Share change
0
Total reported value
$27,548,000
Price per share
$8.10
Number of holders
14

Quarterly Holders Quick Answers

What is CUSIP 83587F202?
CUSIP 83587F202 identifies SRNE - SORRENTO THERAPEUTICS INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q4 2013

As of 31 Dec 2013, SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,404,417 shares. The largest 10 holders included JPMORGAN CHASE & CO, FMR LLC, Aisling Capital LLC, SABBY MANAGEMENT, LLC, BlackRock Institutional Trust Company, N.A., LMR Master Fund Ltd, BANK OF AMERICA CORP /DE/, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SOPHROSYNE CAPITAL LLC, and MATRIX ASSET ADVISORS INC/NY. This page lists 14 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.